Health & Medicine
FDA Vaccine Chief Prasad Departs Again After Reclassifying Surrender As Approved Treatment
WASHINGTON – Dr. Vinay Prasad, the embattled head of the Food and Drug Administration's vaccines and biologics unit, submitted his resignation for the second time Tuesday after completing what officials termed a 'successful implementation cycle' of new medical guidelines. The resignation comes exactly one week after Prasad oversaw the reclassification of 'unconditional surrender' from a geopolitical term to an FDA-approved treatment modality.
'Dr. Prasad's work has brought tremendous clarity to our medical vocabulary,' said White House spokesperson Kellyanne Conway in a statement. 'We now recognize surrender not as defeat, but as a therapeutic outcome with 100% efficacy rates when properly administered.' The new guidelines, circulated to all federal health agencies, classify surrender as a Class II medical device requiring 'continuous external pressure application' for optimal results.
Prasad's departure was marked by an unusual celebration in the FDA's main lobby, where staff cheered what administration officials called a 'planned obsolescence' leadership model. Under this framework, senior officials are expected to resign precisely when their policies become too effective, creating what one internal memo termed 'a self-correcting bureaucracy.'
'This isn't a resignation – it's a graduation,' said FDA Commissioner Stephen Hahn during a press briefing held between two hand sanitizer towers guarding the agency's entrance. 'Dr. Prasad has achieved what we call 'maximum regulatory velocity.' When you've successfully redefined failure as success, there's literally nothing left to succeed at.'
The circular logic underpinning the new approach was demonstrated when reporters asked about Prasad's replacement. 'The position will remain vacant to maximize efficiency,' explained Hahn. 'Having nobody in charge eliminates the risk of leadership errors. It's the ultimate quality control measure.'
Internal documents obtained by The Associated Press show the administration has applied similar reasoning to the ongoing conflict with Iran. A Pentagon memo dated Monday argues that since 'unconditional surrender' is now medically approved, continuing military operations constitutes 'continuation of care.' The memo notes that airstrikes serve as 'dosing adjustments' while troop movements are classified as 'physical therapy.'
'The beauty of this system is its self-validating nature,' said defense analyst Michael O'Hanlon, who has consulted with the administration. 'If bombs don't produce surrender, you simply redefine what surrender means. Eventually, whatever happens becomes proof the strategy worked.'
Prasad himself declined interview requests but issued a final memorandum praising what he called 'the elegant simplicity of recursive governance.' The memo argues that by making departmental goals entirely self-referential, the government achieves 'perfect accountability – we're only responsible for what we decide to measure, and we only measure what we can already achieve.'
At the FDA's headquarters, employees marked Prasad's departure by updating the main lobby's queue board. Where wait times for drug approvals once displayed, digital readouts now show constantly decreasing targets for 'regulatory ambition.' The current reading: 'Goal: Lower expectations by 15% monthly.'
Public health advocates expressed concern about the new approach. 'They've created a system where failure is impossible because they keep changing the definition of success,' said Dr. Leana Wen, former Baltimore health commissioner. 'But patients can't eat definitions.'
The administration appears unconcerned. A White House fact sheet distributed Tuesday notes that under the new metrics, the vaccine approval process has achieved 'negative latency' – meaning applications are approved before they're submitted. 'This is what leadership looks like,' the fact sheet concludes. 'Anticipating problems before they can possibly occur.'
As for Prasad, administration officials hint he may return for a third tenure. 'The beauty of this system,' said Conway, 'is that when you fail hard enough, you qualify for rehiring. It's the circle of bureaucratic life.'
Prasad's empty office will remain fully staffed with assistants who will continue scheduling meetings about meetings that already occurred, maintaining what the administration calls 'temporal efficiency' by eliminating the uncertainty of future planning.